![Norbert Eller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Norbert Eller first degree
Entity | Entity type | Industry | |
---|---|---|---|
Denothex AG
![]() Denothex AG Miscellaneous Commercial ServicesCommercial Services Denothex AG operates as a boutique clinical research organization. It manages clinical trials of all phases across Europe and Israel, with particular focus on biotechnology and medical devices in oncology. The company was founded by Norbert Eller in 1998 and is headquartered in Ettingen, Switzerland.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Norbert Eller via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Basel | College/University | Doctorate Degree | |
Medpace, Inc.
![]() Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace, Inc. provides clinical research services to the pharmaceutical, biotech and medical industries. It offers clinical operations, medical writing, biometrics, regulatory affairs, quality assurance, imaging core lab medical device and risk based monitoring services. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Pharma Brains AG
![]() Pharma Brains AG Miscellaneous Commercial ServicesCommercial Services Pharma Brains AG provides expert clinical development consulting and project management for all phases of clinical research and development of drugs and medical devices. The senior management of the company involves in the launch and distribution of drugs, including elaboration and realization of sales and marketing strategies. The company is uniquely positioned to offer timely access to clinically informative patient populations for rapid confirmation of a projected therapeutic profile and its clinical benefit. In addition to its profound knowledge of the pharmaceutical market, it has access to an excellent network comprising hospitals, experts and pharmaceutical companies and investors all over Europe, the US, Latin America and Israel. | Miscellaneous Commercial Services | Founder | |
University of Milano-Bicocca | College/University | Corporate Officer/Principal | |
Airway Therapeutics, Inc.
![]() Airway Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Airway Therapeutics, Inc. operates as a pharmaceutical company which specializes in the development of surfactant-related products. The firm offers products for the prevention of bronchopulmonary dysplasia, as well as for the treatment of pulmonary infections associated with cystic fibrosis. It also provides pediatric drug development, orphan drug development, pulmonary therapies, protein drug development, neonatal drug therapy, and inhalation drug delivery. The company was founded by Charles McOsker in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
United States | 4 |
Switzerland | 3 |
Italy | 2 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 3 |
Operational
Corporate Officer/Principal | 3 |
President | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Most connected contacts
Insiders | |
---|---|
Marc Salzberg | 7 |
- Stock Market
- Insiders
- Norbert Eller
- Company connections